{
  "patientId": "44556",
  "demographics": {
    "name": "James Wilson",
    "dob": "1950-07-15",
    "gender": "Male",
    "address": "88 Forest Drive, Anytown, USA",
    "phone": "555-4456",
    "insurance": "Medicare + Mutual of Omaha",
    "referringPhysician": "Dr. Charles Brown (Urology)",
    "emergencyContact": "Sarah Wilson (Daughter) - 555-9876",
    "advanceDirectives": "Durable Power of Attorney for Healthcare: Sarah Wilson",
    "supportServices": "Pelvic Floor PT Referral (post-RT), Urology Nurse Coordinator, Prostate Cancer Support Group info.",
    "mobility": "Independent, Ambulatory"
  },
  "diagnosis": {
    "primary": "Prostate Adenocarcinoma",
    "location": "Prostate Gland, Bilateral",
    "grade": "Gleason Score: 4 + 3 = 7 (Grade Group 3)",
    "datePathologicDiagnosis": "01/10/2025 (Prostate Biopsy)",
    "tumorSize": "Dominant nodule ~2.5 cm (MRI)",
    "vascularInvolvement": "No definite lymphovascular invasion identified on biopsy.",
    "pathologicStage": "pT2c N0 M0 (based on biopsy, pending surgery if applicable, currently clinical stage cT2c N0 M0)",
    "clinicalStage": "cT2c N0 M0 (based on DRE, PSA, MRI)",
    "riskGroup": "Favorable High Risk (NCCN)",
    "psaAtDiagnosis": "12.5 ng/mL",
    "symptomsAtPresentation": "Mild urinary frequency, nocturia x2. Found on screening PSA/DRE.",
    "pathologyFindings": [
      "Transrectal Ultrasound (TRUS) guided biopsy results:",
      "Core 1 (Right Apex): Adenocarcinoma, Gleason 4+3=7 (30% pattern 4)",
      "Core 3 (Right Mid): Benign Prostatic Tissue",
      "Core 5 (Left Base): Adenocarcinoma, Gleason 3+4=7 (10% pattern 4)",
      "Total of 2/12 cores positive for adenocarcinoma."
    ],
    "priorProcedures": "None related to cancer treatment prior to ADT/RT.",
    "baselineStatus": "ECOG 0-1",
    "priorTreatmentSummary": "Started Androgen Deprivation Therapy (ADT - Leuprolide) on 02/01/2025."
  },
  "treatmentPlan": {
    "radOnc": "Dr. Maria Garcia",
    "urologist": "Dr. Charles Brown",
    "treatmentSite": "Prostate Gland + Seminal Vesicles",
    "intent": "Definitive (Curative) - Curative intent for localized high-risk prostate adenocarcinoma.",
    "modality": "External Beam Radiation Therapy (EBRT) with Concurrent Androgen Deprivation Therapy (ADT)",
    "totalDose": "79.2 Gy",
    "fractionation": "44 fx",
    "rtRxDetails": "79.2 Gy / 44 fx (1.8 Gy/fx), delivered once daily, 5 days per week.",
    "targetVolumeSummary": "PTV encompassing Prostate gland, bilateral proximal Seminal Vesicles with a 7mm uniform margin, excluding posterior rectum and inferior bladder. GTV defined by MRI/CT fusion.",
    "techniqueSummary": "Volumetric Modulated Arc Therapy (VMAT) - Two full arcs (CW and CCW) to optimize dose distribution and spare surrounding organs.",
    "concurrentChemo": "Androgen Deprivation Therapy (ADT)",
    "detailedConcurrentChemo": "Leuprolide injection (22.5 mg - 3-month depot) started 02/01/2025 (2 months prior to RT start). Planned duration: 18-24 months total. Managed by Urology.",
    "medications": [
      "Tamsulosin 0.4mg daily (for BPH symptoms, continue during RT)",
      "Loperamide PRN Diarrhea (as needed for bowel looseness)",
      "Oxybutynin PRN Urinary Frequency/Urgency (as needed for bladder spasms)",
      "Multivitamin daily (general support)"
    ],
    "therapistAlerts": [
        "Strict bowel/bladder protocol adherence daily.",
        "Verify fiducial markers daily with IGRT.",
        "Patient may experience fatigue from RT and ADT.",
        "Monitor for acute GU/GI toxicity (frequency, urgency, diarrhea, rectal pain)."
    ]
  },
  "radiationOncologyData": {
    "ctSimulation": {
      "simulationDate": "03/10/2025",
      "setupInstructions": "Supine in VacLok bag with ankle immobilization. Custom leg roll for comfort. Full bladder / empty rectum protocol followed strictly. Oral contrast (Omnipaque) given 1 hour prior to scan for small bowel delineation. SAD setup.",
      "immobilization": "VacLok bag (pelvic region), ankle immobilization cushion, custom leg roll.",
      "referenceMarks": "3-point tattoos at isocenter projections (AP and bilateral laterals). Small anterior tattoo for visual alignment.",
      "setupImages": [
        { "type": "AP", "url": "https://placehold.co/250x200/EEE/31343C?text=AP+Setup+Photo" },
        { "type": "Lateral", "url": "https://placehold.co/250x200/EEE/31343C?text=Lateral+Setup+Photo" }
      ],
      "scanner": "Siemens Somatom Definition AS",
      "sliceThickness": "2.5 mm",
      "contrastUsed": "IV Contrast (Ultravist 370) to visualize vasculature and nodal regions. Oral contrast (Omnipaque) for bowel visualization.",
      "ctNotes": "CT acquired after confirming full bladder and empty rectum. Fiducial markers well visualized within the prostate. Scan fused with diagnostic MRI Pelvis (01/20/2025) for comprehensive target and OAR delineation. Isocenter placed to centralize PTV."
    },
    "dosimetry": {
      "planId": "JW44556_Pros_Def",
      "planStatus": "Final - Approved by Dr. Maria Garcia",
      "rx": "79.2 Gy / 44 fx",
      "technique": "VMAT",
      "energy": "6MV FFF",
      "numberOfFieldsOrArcs": 2,
      "gantryAngles": "Arc 1: 181° CW to 179°; Arc 2: 179° CCW to 181°",
      "collAngles": "Arc 1: 0°; Arc 2: 0° (or minor optimal variations)",
      "couchAngles": "0° for both arcs",
      "isoCoords": "L0.0, L+1.0, V-8.0 (relative to scanner coordinates)",
      "tps": "Monaco (Version 5.1)",
      "algorithm": "XVMC",
      "hetero": "Yes (Anisotropic Analytical Algorithm)",
      "norm": "PTV_ProstateSV Mean 95% isodose line",
      "constraints": "Rectum V70Gy < 20%; Bladder V75Gy < 15%; Femoral Head Max < 50 Gy; Small Bowel Dmax < 54 Gy; Rectal Dmax < 79.2 Gy (point dose)",
      "planNotes": "Definitive VMAT plan for localized prostate adenocarcinoma. Daily IGRT to fiducial markers is mandatory for accurate positioning. Patient-specific QA performed and passed. Plan reviewed and signed by Physics and Physician.",
      "igrtProtocol": {
        "frequency": "Daily",
        "type": "kV pair (Orthogonal) or CBCT for fiducial matching",
        "alignment": "Match to implanted fiducial markers in prostate. Verify bladder/rectum filling consistency."
      },
      "qaChecks": [
        { "date": "2025-03-12", "type": "Initial Chart Check", "by": "Physics Staff", "result": "Pass - All data complete & verified." },
        { "date": "2025-03-13", "type": "Patient Specific QA (ArcCHECK)", "by": "Medical Physicist", "result": "Pass - Gamma analysis 99% (3%/3mm)." },
        { "date": "2025-03-24", "type": "Weekly Plan Review", "by": "Dosimetrist", "result": "Pass - No issues identified. Tolerances maintained." }
      ],
      "fieldDetails": [
        { "fieldName": "Arc 1 (CW)", "fieldSize": "Varies with MLC", "gantryAngle": "181° to 179° (CW)", "collimatorAngle": "0", "couchAngle": "0", "energy": "6MV FFF", "monitorUnits": 410, "ssd": "Variable" },
        { "fieldName": "Arc 2 (CCW)", "fieldSize": "Varies with MLC", "gantryAngle": "179° to 181° (CCW)", "collimatorAngle": "0", "couchAngle": "0", "energy": "6MV FFF", "monitorUnits": 405, "ssd": "Variable" }
      ],
      "imagingFields": [
        { "fieldName": "kV Imaging (AP)", "gantryAngle": "0", "fieldSize": "N/A", "energy": "kV", "monitorUnits": "N/A" },
        { "fieldName": "kV Imaging (Lat)", "gantryAngle": "90", "fieldSize": "N/A", "energy": "kV", "monitorUnits": "N/A" }
      ]
    },
    "treatmentDelivery": {
      "fractions": [
        {
          "fractionNumber": 1,
          "totalFractions": 44,
          "date": "2025-03-17",
          "machine": "LINAC 2",
          "fieldsAndMUs": "Arc 1 (410 MU), Arc 2 (405 MU) - Total: 815 MU",
          "energiesUsed": "6MV FFF",
          "setupVerification": "Tolerances Met",
          "immobilizationDevicesChecked": "VacLok bag, ankle immobilization, leg roll",
          "setupAdjustments": "None",
          "organTargetChecks": "kV imaging to fiducials, good match. Bladder full, rectum empty per protocol.",
          "imagingType": "kV Pair",
          "igrtMatchQuality": "Good - No Shifts Required",
          "shiftsApplied": "None",
          "igrtApprovedBy": "Therapist (Auto-match)",
          "igrtVerificationNotes": "Initial setup, fiducials align well.",
          "patientTolerance": "Good",
          "generalSideEffects": "Mild fatigue",
          "siteSpecificSideEffects": "None",
          "painAssessment": "0/10",
          "patientConcerns": "None",
          "instructionsGiven": "Reinforced daily prep, report any new symptoms.",
          "therapistInitials": "JL, KM",
          "billingCodes": "77386, 77387",
          "dailyNotes": "First fraction delivered smoothly. Patient comfortable. Bladder/rectum protocol explained again."
        },
        {
          "fractionNumber": 5,
          "totalFractions": 44,
          "date": "2025-03-21",
          "machine": "LINAC 2",
          "fieldsAndMUs": "Arc 1 (410 MU), Arc 2 (405 MU) - Total: 815 MU",
          "energiesUsed": "6MV FFF",
          "setupVerification": "Adjustments Made",
          "immobilizationDevicesChecked": "VacLok bag, ankle immobilization, leg roll",
          "setupAdjustments": "V: 0.2cm, L: -0.1cm, S: 0.1cm (based on fiducial match)",
          "organTargetChecks": "kV imaging to fiducials, shifts applied. Bladder adequate, small amount of gas in rectum.",
          "imagingType": "kV Pair",
          "igrtMatchQuality": "Good - Shifts Applied",
          "shiftsApplied": "V: 0.2 cm, L: -0.1 cm, S: 0.1 cm",
          "igrtApprovedBy": "Therapist (Fiducial Protocol)",
          "igrtVerificationNotes": "Minor shifts to align fiducials. Rectal gas noted, not impacting target coverage based on imaging.",
          "patientTolerance": "Good",
          "generalSideEffects": "Mild fatigue, occasional mild urinary frequency.",
          "siteSpecificSideEffects": "Increased urinary frequency, managed with Tamsulosin.",
          "painAssessment": "0/10",
          "patientConcerns": "Asking about dietary recommendations for bowel gas.",
          "instructionsGiven": "Reviewed diet for gas reduction (avoiding gassy foods). Continue Tamsulosin.",
          "therapistInitials": "SD, TW",
          "billingCodes": "77386, 77387",
          "dailyNotes": "Patient cooperative. Discussed diet. Shifts applied for fiducials."
        },
        {
          "fractionNumber": 10,
          "totalFractions": 44,
          "date": "2025-03-28",
          "machine": "LINAC 2",
          "fieldsAndMUs": "Arc 1 (410 MU), Arc 2 (405 MU) - Total: 815 MU",
          "energiesUsed": "6MV FFF",
          "setupVerification": "Tolerances Met",
          "immobilizationDevicesChecked": "VacLok bag, ankle immobilization, leg roll",
          "setupAdjustments": "None",
          "organTargetChecks": "Daily CBCT match to fiducial markers. Shifts applied as needed. Good bladder/rectum filling today. Rectal volume appears consistent.",
          "imagingType": "CBCT",
          "igrtMatchQuality": "Good - Shifts Applied",
          "shiftsApplied": "V: -0.1 cm, L: 0 cm, S: -0.1 cm",
          "igrtApprovedBy": "Dr. Garcia (Physician)",
          "igrtVerificationNotes": "Minor shifts based on CBCT and fiducial match. Physician review and approval.",
          "patientTolerance": "Good",
          "generalSideEffects": "Mild increase in urinary frequency noted. Mild fatigue ongoing.",
          "siteSpecificSideEffects": "Mild increase in urinary frequency, occasional mild rectal pressure.",
          "painAssessment": "1/10 (rectal pressure after voiding)",
          "patientConcerns": "Asking about next ADT injection date.",
          "instructionsGiven": "Next ADT injection date confirmed with Urology. Continue current symptom management.",
          "therapistInitials": "JG, RS",
          "billingCodes": "77386, 77387",
          "dailyNotes": "Patient managing ADT side effects (mild hot flashes). Continue to review bowel/bladder management. CBCT review by MD."
        }
      ]
    }
  },
  "imagingAndReports": [
    {
      "date": "01/10/2025",
      "type": "Prostate Biopsy Report",
      "summary": "Adenocarcinoma, Gleason 4+3=7 (Grade Group 3).",
      "reportDetails": {
        "accessionNumber": "P25-00123",
        "specimenSource": "TRUS-guided prostate biopsy (12 cores)",
        "finalDiagnosis": "PROSTATE, TRUS-GUIDED BIOPSY: ADENOCARCINOMA, GLEASON PATTERN 4+3=7, GRADE GROUP 3. Present in 2/12 cores. Largest single focus 5mm.",
        "microscopicDescription": "The prostate biopsy cores show foci of adenocarcinoma with predominant Gleason pattern 4 and a lesser component of Gleason pattern 3. There is cribriform architecture noted. No perineural invasion or lymphovascular invasion identified. Benign prostatic tissue is also present.",
        "comment": "The biopsy findings indicate clinically significant prostate cancer."
      }
    },
    {
      "date": "01/20/2025",
      "type": "MRI Pelvis w/o Contrast (Prostate Protocol)",
      "summary": "Confirms T2c disease, capsule bulging bilaterally, no definite ECE. Seminal vesicles appear clear. PI-RADS 4 lesion.",
      "reportDetails": {
        "accessionNumber": "MR25-54321",
        "findings": "Large, ill-defined lesion in the peripheral zone of the prostate, involving bilateral lobes (anterior/midgland). Appears confined to prostate capsule but with bulging contour. No definite extraprostatic extension (EPE) or seminal vesicle invasion (SVI). No suspicious lymphadenopathy. Osseous structures unremarkable.",
        "impression": "PI-RADS 4 lesion, highly suspicious for clinically significant prostate cancer. Correlates with known biopsy-proven adenocarcinoma."
      }
    },
    {
      "date": "01/25/2025",
      "type": "Bone Scan (Technetium-99m)",
      "summary": "No evidence of osseous metastatic disease. Benign degenerative changes.",
      "reportDetails": {
        "accessionNumber": "NM25-98765",
        "findings": "Symmetrical tracer uptake throughout the skeleton. No focal areas of increased uptake suspicious for metastatic disease. Mild degenerative changes noted in lumbar spine and hips, consistent with age.",
        "impression": "Negative for osseous metastatic disease. Physiologic/degenerative changes."
      },
      "imageSrc": "https://www.mdpi.com/diagnostics/diagnostics-12-02594/article_deploy/html/images/diagnostics-12-02594-g001.png"
    },
    {
      "date": "03/01/2025",
      "type": "Urology Procedure Note - Fiducial Marker Placement",
      "summary": "Placement of 3 gold fiducial markers in prostate under TRUS guidance.",
      "reportDetails": {
        "procedure": "TRUS-guided prostate fiducial marker placement.",
        "indication": "Planned definitive radiation therapy for prostate adenocarcinoma.",
        "findings": "Prostate gland well visualized. 3 gold fiducial markers (1.0 x 3.0mm) successfully deployed into the prostate gland (apex, mid, base) under direct TRUS visualization.",
        "complications": "None immediately, mild hematuria expected.",
        "instructions": "Patient advised of potential mild discomfort and hematuria. Given post-procedure instructions."
      }
    },
    {
      "date": "03/10/2025",
      "type": "CT Simulation (Pelvis - Supine)",
      "summary": "CT acquired with full bladder/empty rectum protocol. Fiducials visualized for planning.",
      "reportDetails": {
        "accessionNumber": "RTCT25-11223",
        "scanType": "Treatment Planning CT (Pelvis)",
        "setup": "Supine, VacLok, Leg roll. Bladder full (400cc), rectum empty (checked with digital rectal exam). Oral contrast administered.",
        "findings": "Prostate gland and fiducial markers clearly visible. Bladder distention adequate and consistent. Rectum appears relatively empty of gas/stool. Scan covers planned treatment volume.",
        "impression": "Adequate CT simulation for prostate VMAT planning with fiducial guidance."
      },
      "imageSrc": "https://ackermancancercenter.com/wp-content/uploads/2022/08/prostate_proton.webp"
    }
  ],
  "dicomImages": [
    { "description": "Diagnostic MRI Pelvis (01/20/2025)", "seriesType": "MR", "ohifViewerUrl": "https://viewer.ohif.org/viewer?StudyInstanceUIDs=1.3.6.1.4.1.5962.99.1.3020871283.19690101000000.1629624997234956830" },
    { "description": "CT Simulation Pelvis (03/10/2025)", "seriesType": "CT", "ohifViewerUrl": "https://viewer.ohif.org/viewer?StudyInstanceUIDs=1.3.6.1.4.1.14519.5.2.1.7009.9007.298806137288633453246975630178" }
  ],
  "labResults": [
    { "date": "12/01/2024", "test": "PSA", "value": "12.5", "units": "ng/mL", "range": "<4.0", "notes": "Baseline at Diagnosis" },
    { "date": "02/15/2025", "test": "Testosterone (Post ADT Start)", "value": "<20", "units": "ng/dL", "range": "Varies", "notes": "Confirms castration level achieved with ADT." },
    { "date": "03/08/2025", "test": "CBC", "value": "WBC 7.2, Hgb 14.5, Plt 250", "units": "K/uL, g/dL, K/uL", "range": "WNL", "notes": "Pre-RT Baseline" },
    { "date": "03/08/2025", "test": "CMP", "value": "Na 139, K 4.0, Cr 1.0, Glu 98", "units": "mEq/L, mEq/L, mg/dL, mg/dL", "range": "WNL", "notes": "Pre-RT Baseline" },
    { "date": "03/24/2025", "test": "PSA", "value": "0.5", "units": "ng/mL", "range": "<4.0", "notes": "During RT, significant drop post-ADT/initial RT." },
    { "date": "04/07/2025", "test": "CBC", "value": "WBC 6.8, Hgb 14.0, Plt 245", "units": "K/uL, g/dL, K/uL", "range": "WNL", "notes": "Mid-treatment, stable." }
  ],
  "progressNotes": [
    { "date": "01/15/2025", "author": "Dr. Charles Brown (Urology)", "type": "Consult Note", "summary": "Pt referred for elevated PSA. Biopsy confirms Gleason 7 (4+3) AdenoCa. Staging T2c N0 M0. Discussed treatment options (Surgery vs RT+ADT). Given age/risk group, pt prefers RT+ADT. Plan to start Leuprolide injection, place fiducials, refer to Rad Onc." },
    { "date": "02/20/2025", "author": "Dr. Maria Garcia (Rad Onc)", "type": "Initial Consult", "summary": "Pt w/ favorable high-risk prostate ca, started on ADT. Plan for definitive EBRT via VMAT to prostate/SVs to 79.2Gy/44fx. Discussed procedure, fiducials/IGRT, bowel/bladder prep, potential side effects (GU/GI toxicity acute & late, ED risk, fatigue). Pt agrees. CT sim scheduled after fiducial placement. Next ADT injection due in 3 months." },
    { "date": "03/01/2025", "author": "Dr. Charles Brown (Urology)", "type": "Procedure Note", "summary": "Successful placement of 3 gold fiducial markers into prostate via TRUS guidance. No complications. Mild hematuria expected for 24-48hrs. Patient tolerating well." },
    { "date": "03/15/2025", "author": "Physics/Dosimetry", "type": "Planning Note", "summary": "VMAT plan completed, meets dose constraints for rectum, bladder, femoral heads. Plan approved by Dr. Garcia. Ready for treatment start 03/17/2025. Daily CBCT/kV to fiducials for IGRT. Weekly physics chart check initiated." },
    { "date": "03/24/2025", "author": "Dr. Maria Garcia (Rad Onc)", "type": "OTV - Week 1", "summary": "Pt completed 5/44 fx. Reports mild increase in urinary frequency (Grade 1 GU), minimal rectal discomfort (Grade 0-1 GI). Tolerating ADT side effects (mild hot flashes) well. Setup/IGRT consistent. PSA decreased to 0.5. Continue RT. Reaffirmed bladder/rectum prep instructions. Encouraged hydration." },
    { "date": "03/28/2025", "author": "Radiation Therapist", "type": "Daily Note", "summary": "Fraction 10/44. Patient reports continued mild urinary frequency. Bladder scanned and full. Rectum appears empty. Fiducial match within tolerance, minor shifts applied. Patient cooperative. No acute skin reaction noted." }
  ],
  "patientEducation": {
    "goalsDiscussed": "Definitive (curative) treatment for localized high-risk prostate cancer. Explain role of ADT in conjunction with RT. Discuss importance of long-term follow-up for PSA monitoring.",
    "sideEffectsReviewed": "Acute (during RT): Increased urinary frequency/urgency, painful urination (dysuria), rectal discomfort, diarrhea (Grade 1-2 expected). Fatigue. Late (months-years post-RT): Rectal bleeding (proctitis), urinary incontinence, erectile dysfunction (ED). ADT side effects: hot flashes, fatigue, decreased libido, potential for bone density loss.",
    "safetyConsiderations": "Crucial: Daily full bladder/empty rectum protocol. Use of fiducial markers for precise targeting and minimizing exposure to healthy tissue. Report any severe or worsening symptoms (e.g., fever, severe pain, inability to urinate).",
    "patientResponsibilities": "Adhere to daily bowel/bladder preparation. Attend all daily RT sessions. Continue ADT as prescribed by Urology. Report all side effects promptly. Maintain hydration and balanced diet. Engage in light exercise as tolerated.",
    "medicationCompliance": "Continue Tamsulosin as prescribed. Instructions for PRN Loperamide/Oxybutynin as needed. Emphasize importance of ADT compliance for treatment efficacy. Reviewed interactions with OTC medications/supplements. Provided contact numbers for nurse/physician for urgent concerns."
  },
  "scheduling": [
    { "date": "01/10/2025", "time": "9:00 AM", "type": "Prostate Biopsy", "location": "Urology Clinic", "status": "Completed", "notes": "Pathology confirmed Gleason 4+3=7." },
    { "date": "01/20/2025", "time": "1:00 PM", "type": "MRI Pelvis", "location": "Radiology Department", "status": "Completed", "notes": "Confirms T2c, no EPE/SVI." },
    { "date": "01/25/2025", "time": "10:00 AM", "type": "Bone Scan", "location": "Nuclear Medicine", "status": "Completed", "notes": "Negative for metastatic disease." },
    { "date": "01/30/2025", "time": "11:00 AM", "type": "Urology Follow Up (Discuss Results/Plan)", "location": "Urology Clinic", "status": "Completed", "notes": "Decision for RT+ADT. Leuprolide order placed." },
    { "date": "02/01/2025", "time": "N/A", "type": "ADT Injection (Leuprolide) Start", "location": "Urology Clinic", "status": "Completed", "notes": "First 3-month depot injection." },
    { "date": "02/20/2025", "time": "2:00 PM", "type": "Rad Onc Consult (Dr. Garcia)", "location": "Radiation Oncology Clinic", "status": "Completed", "notes": "Detailed discussion of RT plan and side effects. Agreed to proceed." },
    { "date": "03/01/2025", "time": "10:00 AM", "type": "Fiducial Marker Placement", "location": "Urology Procedure Room", "status": "Completed", "notes": "3 gold markers placed." },
    { "date": "03/10/2025", "time": "9:00 AM", "type": "CT Simulation Pelvis", "location": "Radiation Oncology Simulation Suite", "status": "Completed", "notes": "Full bladder/empty rectum protocol followed. Scanned with fiducials." },
    { "date": "03/17/2025", "time": "1:00 PM", "type": "VMAT Radiation Treatment (Fraction 1/44)", "location": "LINAC 2", "status": "Completed", "notes": "Treatment start date." },
    { "date": "03/24/2025", "time": "1:30 PM", "type": "On-Treatment Visit (OTV) - Week 1", "location": "Radiation Oncology Clinic", "status": "Completed", "notes": "Reviewed acute side effects. PSA 0.5. Stable." },
    { "date": "03/28/2025", "time": "1:00 PM", "type": "VMAT Radiation Treatment (Fraction 10/44)", "location": "LINAC 2", "status": "Completed", "notes": "Routine treatment." },
    { "date": "04/07/2025", "time": "1:30 PM", "type": "On-Treatment Visit (OTV) - Week 4", "location": "Radiation Oncology Clinic", "status": "Scheduled", "notes": "Anticipate review of mid-treatment symptoms." },
    { "date": "05/16/2025", "time": "1:00 PM", "type": "VMAT Radiation Treatment (Fraction 44/44) - Last Day", "location": "LINAC 2", "status": "Scheduled", "notes": "Final treatment session." }
  ],
  "cptCharges": [
    { "code": "55876", "description": "Placement of interstitial device(s) for radiation therapy guidance (e.g., fiducial markers), prostate", "frequency": "Once (03/01/2025)" },
    { "code": "77290", "description": "Therapeutic radiology simulation-aided field setting, complex (Pelvis for IMRT/VMAT)", "frequency": "Once (03/10/2025)" },
    { "code": "77334", "description": "Treatment device, complex (VacLok, custom immobilization)", "frequency": "Once (Initial Setup)" },
    { "code": "77301", "description": "IMRT planning (includes target/OAR contouring, dose calculation)", "frequency": "Once (Per plan)" },
    { "code": "77338", "description": "MLC device for IMRT/VMAT", "frequency": "Once (Per plan)" },
    { "code": "77300", "description": "Basic radiation dosimetry calculation", "frequency": "Per plan (for verification)" },
    { "code": "77386", "description": "IMRT delivery, complex (VMAT), daily treatment", "frequency": "Daily (44 total)" },
    { "code": "77387", "description": "Image Guided RT (IGRT - CBCT/kV for fiducials), daily", "frequency": "Daily (44 total)" },
    { "code": "77427", "description": "Radiation treatment management, 5 treatments", "frequency": "Weekly (9 total)" },
    { "code": "99214", "description": "Office or other outpatient visit, established patient", "frequency": "Weekly (for OTVs as appropriate)" }
  ],
  "diagnosisSearch": "Prostate Cancer, Adenocarcinoma, Pelvis Radiation"
}
